Stanford University Gomez-Ospina Lab

The Gomez-Ospina Lab at Stanford University is dedicated to developing precise genetic medicines for patients with genetic diseases, focusing on childhood neurodegenerative diseases such as lysosomal storage disorders. Dr. Natalia Gomez Ospina leads the lab in utilizing genome editing and stem cells to create definitive treatments, with ongoing projects targeting diseases like mucopolysaccharidosis type I and Gaucher disease.

Dr. Gomez Ospina, a board-certified medical geneticist, oversees clinical evaluations and diagnoses of patients with genetic conditions while also spearheading research to advance gene and cell-based therapies for metabolic diseases. The lab welcomes students, postdocs, and research assistants to join their efforts in developing innovative treatments for genetic disorders.

Generated from the website